rxstat › Shortages › Donepezil

Donepezil shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Donepezil products are in shortage in Canada (14 of 39 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 10, 2026.
Products affected
14 / 39
In shortage since
Nov 28, 2018
Est. full return
Oct 10, 2026
Reports on file
101
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
PMS-DONEPEZIL
5MG · TABLET · PHARMASCIENCE INC
DIN 02322331 · since Jun 26, 2026, est. end Jul 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-DONEPEZIL TABLETS
5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02416948 · since Apr 21, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
ARICEPT
10MG · TABLET · PFIZER CANADA ULC
DIN 02232044 · since Apr 21, 2026, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ARICEPT
5MG · TABLET · PFIZER CANADA ULC
DIN 02232043 · since Apr 21, 2026, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
TEVA-DONEPEZIL
5MG · TABLET · TEVA CANADA LIMITED
DIN 02340607 · since Jan 30, 2025, est. end Oct 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACH-DONEPEZIL
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02402653 · since Nov 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-DONEPEZIL
5MG · TABLET · APOTEX INC
DIN 02362260 · since Nov 18, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-DONEPEZIL
10MG · TABLET · APOTEX INC
DIN 02362279 · since Aug 6, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
NAT-DONEPEZIL
5MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02439557 · since Jun 13, 2024, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-DONEPEZIL
10MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02439565 · since Apr 21, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-DONEPEZIL
5MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02439557 · since Jun 13, 2024, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-DONEPEZIL
10MG · TABLET · TEVA CANADA LIMITED
DIN 02340615 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Donepezil is currently affected by 14 active shortage reports filed with Health Canada by PHARMASCIENCE INC, JAMP PHARMA CORPORATION, PFIZER CANADA ULC, TEVA CANADA LIMITED and 5 others.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Donepezil is classified under “ANTI-DEMENTIA DRUGS” (ATC N06DA).

Recent changes

Common questions

When will Donepezil be back in stock in Canada?

The latest manufacturer estimate is Oct 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Donepezil in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (anti-dementia drugs)

Partial shortageMemantine2 of 12 reported products affected · est. return Jul 11, 2026Partial shortageRivastigmine1 of 30 reported products affected · est. return Sep 15, 2025No current shortageGalantamine

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.